• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Time course of restenosis during the first year after emergency coronary stenting.

作者信息

Kastrati A, Schömig A, Dietz R, Neumann F J, Richardt G

机构信息

I. Medizinische Klinik, Technical University of Munich, Germany.

出版信息

Circulation. 1993 May;87(5):1498-505. doi: 10.1161/01.cir.87.5.1498.

DOI:10.1161/01.cir.87.5.1498
PMID:8491004
Abstract

BACKGROUND

Prevention of abrupt vessel closure after percutaneous transluminal coronary angioplasty (PTCA) represents one of the current indications for intracoronary stent implantation. After the procedure, the stented segment undergoes luminal changes that may lead to late restenosis. This study was undertaken to assess the time course of luminal changes during the first year after emergency placement of coronary stents.

METHODS AND RESULTS

Coronary stenting was indicated in patients with present or threatened vessel closure secondary to large dissections after PTCA. From June 1989 to May 1991, 82 patients who received Palmaz-Schatz stents and did not have early vessel occlusion after stenting were enrolled into a serial angiographic follow-up study. Coronary normal reference diameter and minimal luminal diameter were measured with an automated edge detection technique. Patients who underwent repeat PTCA for restenosis were excluded from further serial angiography. The restudy rate at 3, 6, and 12 months was 96%, 81%, and 90% of the eligible patients, respectively. The incidence of restenosis (defined as a diameter stenosis > or = 50%) was 22.0% at 3 months, 31.9% at 6 months, and 33.2% at 12 months. Minimal luminal diameter was increased from 0.66 +/- 0.32 mm before to 2.85 +/- 0.43 mm immediately after stenting. It was 0.46 +/- 0.31 mm smaller than the diameter of the maximally inflated balloon during the procedure. The reduction in minimal luminal diameter was 0.80 +/- 0.69 mm (p = 0.0001) for the first 3 months, 0.29 +/- 0.52 mm (p = 0.0001) between 3 and 6 months, and 0.13 +/- 0.32 mm (p = 0.01) for the last 6 months. The percentage of patients who presented a significant change in minimal luminal diameter (defined as > 0.60 mm) declined from 50.6% during the first 3 months and 18.9% between 3 and 6 months to 6.5% for the period between 6 and 12 months.

CONCLUSIONS

The incidence and the time course of restenosis after emergency coronary stenting are similar to that reported for conventional PTCA. Coronary lumen dimensions demonstrated a peak change at 3 months and remained mostly stable after the first 6 months.

摘要

相似文献

1
Time course of restenosis during the first year after emergency coronary stenting.
Circulation. 1993 May;87(5):1498-505. doi: 10.1161/01.cir.87.5.1498.
2
Emergency coronary stenting for dissection during percutaneous transluminal coronary angioplasty: angiographic follow-up after stenting and after repeat angioplasty of the stented segment.经皮腔内冠状动脉成形术期间夹层的紧急冠状动脉支架置入术:支架置入后及支架段重复血管成形术后的血管造影随访
J Am Coll Cardiol. 1994 Apr;23(5):1053-60. doi: 10.1016/0735-1097(94)90589-4.
3
Single bailout stenting for threatened coronary closure complicating balloon angioplasty: acute and mid-term outcome.针对球囊血管成形术并发的濒临冠状动脉闭塞进行单支架挽救性置入术:急性和中期结果
Coron Artery Dis. 1996 Apr;7(4):327-33. doi: 10.1097/00019501-199604000-00010.
4
Four-year experience with Palmaz-Schatz stenting in coronary angioplasty complicated by dissection with threatened or present vessel closure.
Circulation. 1994 Dec;90(6):2716-24. doi: 10.1161/01.cir.90.6.2716.
5
Clinical and angiographic outcomes after coronary artery stenting for acute or threatened closure after percutaneous transluminal coronary angioplasty. Initial results with a balloon-expandable, stainless steel design.经皮腔内冠状动脉成形术后急性或濒临闭塞行冠状动脉支架置入术的临床及血管造影结果。球囊扩张式不锈钢设计的初步结果。
Circulation. 1993 Nov;88(5 Pt 1):2086-96. doi: 10.1161/01.cir.88.5.2086.
6
Serial angiographic follow-up after Palmaz-Schatz stent implantation: comparison with conventional balloon angioplasty.Palmaz-Schatz支架植入术后的系列血管造影随访:与传统球囊血管成形术的比较。
J Am Coll Cardiol. 1993 Jun;21(7):1557-63. doi: 10.1016/0735-1097(93)90368-b.
7
[Percutaneous transluminal coronary angioplasty for restenosis following Palmaz-Schatz stenting: larger size balloons are more effective?].
J Cardiol. 1999 Aug;34(2):55-60.
8
Emergent use of balloon-expandable coronary artery stenting for failed percutaneous transluminal coronary angioplasty.对于经皮腔内冠状动脉成形术失败后紧急使用球囊扩张式冠状动脉支架置入术。
Circulation. 1992 Sep;86(3):812-9. doi: 10.1161/01.cir.86.3.812.
9
Differences in restenosis propensity of devices for transluminal coronary intervention. A quantitative angiographic comparison of balloon angioplasty, directional atherectomy, stent implantation and excimer laser angioplasty. CARPORT, MERCATOR, MARCATOR, PARK, and BENESTENT Trial Groups.经皮冠状动脉介入治疗器械再狭窄倾向的差异。球囊血管成形术、定向旋切术、支架植入术和准分子激光血管成形术的定量血管造影比较。CARPORT、MERCATOR、MARCATOR、PARK和BENESTENT试验组。
Eur Heart J. 1995 Oct;16(10):1331-46. doi: 10.1093/oxfordjournals.eurheartj.a060740.
10
The importance of acute luminal diameter in determining restenosis after coronary atherectomy or stenting.
Circulation. 1992 Dec;86(6):1827-35. doi: 10.1161/01.cir.86.6.1827.

引用本文的文献

1
Research progress of drug eluting balloon in arterial circulatory system.药物洗脱球囊在动脉循环系统中的研究进展
Front Cardiovasc Med. 2024 Mar 20;11:1287852. doi: 10.3389/fcvm.2024.1287852. eCollection 2024.
2
Treatment of In-stent Restenosis of the Internal Carotid Artery Using Drug-eluting Balloons.药物涂层球囊治疗颈内动脉支架内再狭窄。
Clin Neuroradiol. 2024 Mar;34(1):147-154. doi: 10.1007/s00062-023-01343-6. Epub 2023 Sep 7.
3
Caffeic Acid-Grafted PLGA as a Novel Material for the Design of Fluvastatin-Eluting Nanoparticles for the Prevention of Neointimal Hyperplasia.
阿魏酸接枝聚乳酸-乙醇酸共聚物作为设计氟伐他汀洗脱纳米粒子用于预防内膜增生的新型材料。
Mol Pharm. 2022 Nov 7;19(11):4333-4344. doi: 10.1021/acs.molpharmaceut.2c00693. Epub 2022 Oct 17.
4
Inflammatory Phenotype by OCT Coronary Imaging: Specific Features Among De Novo Lesions, In-Stent Neointima, and In-Stent Neo-Atherosclerosis.OCT 冠状动脉成像的炎症表型:新发病变、支架内新生内膜和支架内新动脉粥样硬化中的特定特征。
Arq Bras Cardiol. 2022 Dec;119(6):931-937. doi: 10.36660/abc.20220045.
5
Management of in-stent restenosis.支架内再狭窄的处理。
EuroIntervention. 2022 Jun 3;18(2):e103-e123. doi: 10.4244/EIJ-D-21-01034.
6
Coronary In-Stent Restenosis: Predictors and Treatment.冠状动脉支架内再狭窄:预测因素与治疗。
Dtsch Arztebl Int. 2021 Sep 24;118(38):637-644. doi: 10.3238/arztebl.m2021.0254.
7
Evaluation of Mechanical Performances of Stents with 38 mm Length in Long Lesion.评价 38mm 长度支架在长病变中的机械性能。
Biomed Res Int. 2020 Feb 27;2020:2594161. doi: 10.1155/2020/2594161. eCollection 2020.
8
Swine model of in-stent stenosis in the iliac artery evaluating the serial time course.评估连续时间进程的髂动脉支架内狭窄猪模型。
Exp Anim. 2018 Nov 1;67(4):501-508. doi: 10.1538/expanim.18-0027. Epub 2018 Aug 1.
9
Identification of genomic differences among peripheral arterial beds in atherosclerotic and healthy arteries.鉴定粥样硬化和健康动脉周围动脉床的基因组差异。
Sci Rep. 2018 Mar 2;8(1):3940. doi: 10.1038/s41598-018-22292-y.
10
Stent thrombosis and restenosis: what have we learned and where are we going? The Andreas Grüntzig Lecture ESC 2014.支架内血栓形成与再狭窄:我们学到了什么,又将何去何从?2014年欧洲心脏病学会安德烈亚斯·格鲁恩齐格讲座
Eur Heart J. 2015 Dec 14;36(47):3320-31. doi: 10.1093/eurheartj/ehv511. Epub 2015 Sep 28.